A. K. Sanki, T. Pathak / Tetrahedron 59 (2003) 7203–7214
7209
Eluent: EtOAc:pet ether (1:3). Brown gum. IR (CHCl3):
1722, 1596, 1494 cm21. [a]D26¼216.2 (c 1.004, CHCl3). 1H
NMR: d 7.75 (2H, d, J¼8.3 Hz, aromatic), 7.30 (7H, m,
aromatic), 6.60 (1H, s), 5.72 (1H, s), 4.95 (1H, d, J¼6.3 Hz),
4.47 (2H, s, PhCH2), 3.83 (1H, dd, J¼10.7, 2.4 Hz), 3.50
(1H, m), 3.42 (3H, s, OMe), 2.43 (3H, s, aromatic Me). 13C
NMR: d 147.6, 136.6, 145.3, 138.2, 136.3, 130.0, 128.3,
127.5, 107.3 (C-1), 83.4, 73.2 (CH2), 72.0 (CH2), 55.3
(OMe), 21.6 (aromatic Me). MS: m/z (EI) 250 (6Mþ2124),
236 (91Mþ2138), 218 (13Mþ2156), 139 (16), 105 (17),
91 (100), 77 (30), 65 (46). Anal. calcd for C20H22O5S:
C, 64.15; H, 5.91; S, 8.56. Found: C, 64.41; H, 6.36; S,
8.81.
129.7, 128.6, 127.8, 127.0, 109.4, 87.1, 83.1, 81.3, 63.8
(CH2), 54.9 (OMe), 53.5, 20.9 (aromatic Me). MS: m/z (EI)
512 (4Mþ), 270 (2), 259 (2), 251 (3), 244 (8), 243 (100).
Anal. calcd for C32H32O4S.1H2O: C, 72.43; H, 6.07; S, 6.04.
Found: C, 72.25; H, 6.45; S, 5.73.
4.4.7. Methyl 5-O-benzyl-3-deoxy-3-C-(p)-tolylsulfonyl-
a-D-arabinofuranoside 9. Compound
7
(0.59 g,
1.652 mmol) was converted to 9 following the general
procedure described above (0.6 g, 93%). Eluent: EtOAc:pet
ether (1:4). Brown gum. [a]2D6¼þ95.2 (c 1.00, CHCl3). IR
(Neat on KBr plate): 3481, 3062, 3030, 2925, 1596, 1494,
1454, 1402, 1363 cm21. 1H NMR: d 7.73 (2H, d, J¼8.3 Hz,
aromatic), 7.29 (7H, m, aromatic), 4.86 (1H, s, H-1), 4.48
(5H, m), 3.69 (2H, m), 3.33 (1H, dd, J¼11.3 (10.8), 3.9
(3.4) Hz), 3.25 (3H, s, OMe), 2.39 (3H, s, aromatic Me). 13C
NMR: d 144.9, 137.3, 134.9, 129.6, 128.3, 128.1, 127.5,
108.9, 77.2, 77.0, 73.1 (CH2), 71.0, 69.4 (CH2), 54.5 (OMe),
21.2 (aromatic Me). MS: m/z (EI) 392 (,1.0Mþ), 343 (0.3),
301 (0.4), 271 (0.6), 262 (1.2), 243 (0.9), 205 (4), 155 (7),
107 (32), 92 (14), 91 (100). Anal. calcd for
C20H24O6S.0.25H2O: C, 60.50; H, 6.21; S, 8.07. Found:
C, 60.43; H, 6.46; S, 8.21.
4.4.4. Methyl 2,3-dideoxy-3-C-(p)-tolylsulfonyl-5-O-tri-
tyl-b-D-erythro-pent-2-enofuranoside 3b. Compound 16
(0.46 g, 0.838 mmol) was converted to 3b following the
general procedure described earlier (0.37 g, 84%). Eluent:
EtOAc:pet ether (1:4). White needle shaped crystal. Mp:
131–1328C. [a]2D6¼þ11.4 (c 1.012, CHCl3). IR (Nujol):
3097, 3051, 3028, 1593, 1490, 1463, 1448, 1377 cm21. 1H
NMR: d 7.53 (2H, d, J¼8.3 Hz, aromatic), 7.42 (6H, dd,
J¼8.3, 2.4 Hz, aromatic), 7.34–7.25 (9H, m, aromatic),
7.17 (2H, d, J¼7.8 Hz, aromatic), 6.64 (1H, t, J¼1.5,
1.4 Hz, H-2), 5.78 (1H, s, H-1), 5.00 (1H, d, J¼6.8 Hz), 3.48
(3H, s, OMe), 3.37 (1H, dd, J¼10.3, 2.0 Hz), 3.09 (1H, dd,
J¼10.3, 6.8 Hz), 2.41 (3H, s, aromatic Me). 13C NMR: d
147.4, 145.1, 143.9, 136.9, 136.2, 130.1, 128.9, 128.0,
127.1, 107.7 (C-1), 86.7, 83.7, 66.0 (CH2), 55.9, 21.7
(aromatic Me). MS: m/z (EI) 526 (0.1Mþ), 494 (0.1), 450
(0.8), 449 (0.9), 267 (0.9), 243 (100), 165 (36), 91 (16), 77
(9). Anal. calcd for C32H30O5S: C, 72.98; H, 5.73. Found: C,
73.12; H, 5.72.
4.4.8. Methyl 3-deoxy-3-C-(p)-tolylsulfonyl-5-O-trityl-a-
(3.82 g,
D-arabinofuranoside
10.
Compound
8
7.460 mmol) was converted to 10 following the general
procedure described above (3.31 g, 81%). Eluent: EtOAc:
pet ether (3:7). White needle shaped solid. Mp: 70–718C.
[a]2D5¼þ81.7 (c 1.01, CHCl3). IR (CHCl3): 3479, 1637,
1596, 1492 cm21
.
1H NMR: d 7.62 (2H, d, J¼8.3 Hz,
aromatic), 7.29 (17H, m, aromatic), 5.03 (1H, d, J¼2.0 Hz,
H-1), 4.64 (1H, m), 4.49 (1H, m), 3.80 (1H, m), 3.45 (1H,
dd, J¼10.8, 2.0 Hz), 3.37 (3H, s, OMe), 2.73 (2H, m), 2.42
(3H, s, aromatic Me). 13C NMR: d 145.1, 143.7, 135.3,
130.0, 128.7, 128.5, 127.9, 127.2, 109.0, 86.9, 77.3, 71.4,
63.9 (CH2), 55.3, 21.7 (aromatic Me). MS: m/z (EI) 287 (1),
259 (1), 244 (6), 243 (100), 228 (3), 165 (19). Anal. calcd
for C32H32O6S.1H2O: C, 68.31; H, 5.72; S, 5.69. Found: C,
68.01; H, 5.62; S, 6.78.
4.4.5. Methyl 5-O-benzyl-3-deoxy-3-C-(p)-tolylsulfide-a-
D-arabinofuranoside 7. Compound 5 (0.57 g, 2.43 mmol)
was converted to 7 following the general procedure
described above (0.81 g, 92%). Eluent: EtOAc:pet ether
(1:4). Brown oil. [a]2D6¼þ128.8 (c 1.00, CHCl3). IR (neat on
KBr plate): 3438, 3062, 3030, 2866, 2833, 1596, 1494,
1454, 1400 cm21. 1H NMR: d 7.30 (7H, m, aromatic), 7.06
(2H, d, J¼8.3 Hz, aromatic), 4.92 (1H, s, H-1), 4.61 (1H, d,
J¼12.2 Hz), 4.48 (1H, d, J¼11.8 Hz), 4.42 (1H, m), 4.13
(1H, d, J¼10.0 Hz), 3.77 (1H, dd, J¼10.7, 2.0 Hz), 3.56
(1H, d, J¼9.8 Hz), 3.44 (2H, m), 3.38 (3H, s, OMe), 2.29
(3H, s, aromatic Me). 13C NMR: d 137.2, 136.6, 131.1,
129.5, 128.1, 127.5, 109.4 (C-1), 82.9, 81.0, 73.0 (CH2),
69.4 (CH2), 54.6 (OMe), 52.9, 20.6 (aromatic Me). MS: m/z
(EI) 360 (9Mþ), 328 (2), 221 (1), 189 (1), 179 (3), 165 (5),
124 (39), 91 (100). Anal. calcd for C20H24O4S: C, 66.64; H,
6.70; S, 8.89. Found: C, 66.34; H, 7.34: S, 8.89.
4.4.9. Methyl 5-O-benzyl-3-deoxy-3-C-(p)-tolylsulfide-b-
D-xylofuranoside 13. Compound 11 (0.44 g, 1.851 mmol)
was converted to 13 following the general procedure
described above (0.53 g, 79%). Eluent: EtOAc:pet ether
(1:9). Brown gum. [a]3D0¼þ16.1 (c 1.04, CHCl3). IR (neat):
3425, 3062, 3031, 2923, 2862 cm21. 1H NMR: d 7.28 (7H,
m, aromatic), 7.03 (2H, d, J¼8.3 Hz, aromatic), 4.81 (1H, d,
J¼1.9 Hz, H-1), 4.60 (1H, m), 4.54 (2H, s, PhCH2), 4.25
(1H, dd, J¼4.9, 1.9 Hz), 3.76–3.63 (3H, 2£m), 3.36 (3H, s,
OMe), 3.25 (1H, broad hump, OH), 2.27 (3H, s, aromatic
Me). 13C NMR: d 138.0, 136.0, 132.2, 130.3, 129.7, 128.1,
127.7, 127.4, 109.4 (C-1), 81.1, 79.9, 73.1 (CH2), 71.2
(CH2), 55.3 (OMe), 54.7, 20.8 (aromatic Me). MS: m/z (EI)
360 (11Mþ), 328 (11), 149 (20), 135 (15), 124 (41), 91
(100). Anal. calcd for C20H24O4S: C, 66.64; H, 6.70; S,
8.89. Found: C, 66.32; H, 7.24; S, 8.81.
4.4.6. Methyl 3-deoxy-3-C-(p)-tolylsulfide-5-O-trityl-a-
D-arabinofuranoside 8. Compound 6 (5.1 g, 13.13 mmol)
was converted to 8 following the general procedure
described above (4.61 g, 69%). Eluent: EtOAc:pet ether
(3:7). Colorless gum. [a]2D5¼þ74.2 (c 1.09, CHCl3). IR
1
(CHCl3): 3442, 2831, 1666, 1492 cm21. H NMR: d 7.28
(17H, m, aromatic), 6.98 (2H, d, J¼8.3 Hz, aromatic), 4.99
(1H, s, H-1), 4.15 (2H, a broad hump), 3.56 (1H, dd, J¼10.3,
2.5 Hz), 3.39 (3H, s, OMe), 3.35 (1H, m), 3.05 (1H, dd,
J¼11.3, 4.0 Hz), 2.80 (1H, d, J¼2.5 Hz, OH), 2.27 (3H, s,
aromatic Me). 13C NMR: d 143.5, 136.8, 131.4, 131.2,
4.4.10. Methyl 3-deoxy-3-C-(p)-tolylsulfide-5-O-trityl-b-
D-xylofuranoside 14. Compound 12 (1.3 g, 3.37 mmol) was
converted to 14 following the general procedure described
above (1.64 g, 95%). Eluent: EtOAc:pet ether (1:9). White
plate shaped solid. Mp: 114–1158C. [a]2D6¼þ56.9 (c 1.008,